RecruitingNCT05816850
Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial
Studying Non-Hodgkin lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Principal Investigator
- Simone Ferrero, MDSC Ematologia U - AOU Città della Salute e della Scienza di Torino
- Intervention
- EZH2 mutations/CNAs by droplet digital PCR (ddPCR)(diagnostic_test)
- Enrollment
- 654 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2027
Study locations (26)
- A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia, Alessandria, Italy
- Nuovo Ospedale degli Infermi, SSD Ematologia, Biella, Italy
- ASST Spedali Civili di Brescia - Ematologia, Brescia, Italy
- Azienda Ospedaliera Universitaria Policlinico - S. Marco, UOC di Ematologia, Catania, Italy
- A.O. S. Croce e Carle, S.C. di Ematologia e Trapianto di Midollo Osseo, Cuneo, Italy
- Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia, Florence, Italy
- Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia, Ematologia e terapie cellulari, Genova, Italy
- IRCCS Istituto Romagnolo per lo studio dei Tumori "Dino Amadori" - IRST S.R.L., Ematologia, Meldola, Italy
- ASST Grande Ospedale Metropolitano Niguarda, SC Ematologia, Milan, Italy
- Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Ematologia, Milan, Italy
- Azienda Ospedaliero-Universitaria Policlinico di Modena, U.O. Oncologia, Modena, Italy
- Fondazione IRCCS San Gerardo dei Tintori - Ematologia, Monza, Italy
- AOU Maggiore della Carità di Novara, SCDU Ematologia, Novara, Italy
- Presidio ospedaliero "A. Tortora", U.O. Onco-ematologia, Pagani, Italy
- A.O. Ospedali Riuniti Villa Sofia-Cervello, Divisione di Ematologia, Palermo, Italy
- +11 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05816850 on ClinicalTrials.govOther trials for Non-Hodgkin lymphoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07222631SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin LymphomasUniversity of California, San Diego
- RECRUITINGNCT07313943PAX5-NEGATIVE HODGKIN-LIKE LYMPHOMAS: A DIAGNOSTIC CHALLANGEIRCCS Azienda Ospedaliero-Universitaria di Bologna
- RECRUITINGPHASE2NCT07283822Amping up With PemJAKSeda S. Tolu
- RECRUITINGPHASE1NCT07284927Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid MalignanciesPersonGen BioTherapeutics (Suzhou) Co., Ltd.
- RECRUITINGPHASE2NCT07285590Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell LymphomaGrupo Español de Linfomas y Transplante Autólogo de Médula Ósea
- RECRUITINGPHASE1NCT07283796A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's LymphomaHaisco Pharmaceutical Group Co., Ltd.
- RECRUITINGPHASE1, PHASE2NCT06838832Novel Allogenic CD19-targeting CAR-γδT Cell Therapy (QH103E) in r/r NHLChinese PLA General Hospital
- RECRUITINGNANCT06923397Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND TrialDana-Farber Cancer Institute